Funded Startups in Vaud
Among the 5 most recent funded entries tied to Vaud/Geneve, one disclosed round stands out: Neo Medical’s $69M Series B on 2024-09-17.
Among the 5 most recent funded entries tied to Vaud/Geneve, one disclosed round stands out: Neo Medical’s $69M Series B on 2024-09-17. Every other disclosed amount shown is $2M (TYXIT on 2022-10-25, Isochronic on 2022-05-13, and Droople on 2021-05-05), making Neo Medical’s disclosed size an outlier relative to the rest.
Geographically, all 5 rows list “Vaud, Geneve, Switzerland,” so city-level clustering is uniform rather than diversified. Temporally, the set spans from 2021-05-05 (Droople) through 2025-07-29 (TeraSol), with only one entry in 2025 (TeraSol, Seed with undisclosed amount). Stage mix is also skewed: Seed appears twice with disclosed $2M rounds (TYXIT, Isochronic) and one additional Seed entry (TeraSol) with undisclosed funding.
Most recent rounds
5 shownRelated listings
Frequently asked
What is the largest disclosed round here, and how does it compare to the other disclosed amounts?
Neo Medical’s $69M Series B (2024-09-17) is the only disclosed round above $50M. The next-largest disclosed amounts in the list are $2M each: TYXIT (Seed, 2022-10-25), Isochronic (Seed, 2022-05-13), and Droople (2021-05-05).
Do these Vaud/Geneve entries cluster in time, or are they spread across multiple years?
They’re spread from 2021-05-05 (Droople) to 2025-07-29 (TeraSol). Within that window, there’s a concentration of Seed activity in 2022: Isochronic ($2M on 2022-05-13) and TYXIT ($2M on 2022-10-25).
Is there a sector (or sectors) represented across multiple entries?
No sector repeats in 3+ entries. Each sector appears once across the 5 rows: Professional Services (TeraSol), Health Care (Neo Medical), Media and Entertainment (TYXIT), Manufacturing (Isochronic), and Financial Services (Droople).
Which stage types dominate this slice, and how does disclosed sizing vary by stage?
Seed is the most frequent stage label in the rows: TeraSol (Seed, 2025-07-29, undisclosed), TYXIT (Seed, $2M on 2022-10-25), and Isochronic (Seed, $2M on 2022-05-13). Outside Seed, Neo Medical is the only Series B (2024-09-17) and it carries the large disclosed outlier ($69M).
Are there notable outliers besides Neo Medical’s size?
Yes: TeraSol’s 2025-07-29 Seed round is an outlier in disclosure status, with “undisclosed” instead of a stated amount, while the rest of the disclosed amounts shown are either $69M (Neo Medical) or $2M (TYXIT, Isochronic, Droople).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.